Longboard Pharmaceuticals, Inc. (LBPH)
NASDAQ: LBPH · IEX Real-Time Price · USD
19.72
+0.47 (2.44%)
At close: Apr 26, 2024, 4:00 PM
20.70
+0.98 (4.97%)
After-hours: Apr 26, 2024, 7:59 PM EDT

Longboard Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Selling, General & Admin
13.0110.168.079.77
Research & Development
43.7534.6419.774.63
Operating Expenses
56.7644.827.8414.4
Operating Income
-56.76-44.8-27.84-14.4
Other Expense / Income
-2.34-0.85-0.04-
Pretax Income
-54.42-43.95-27.8-14.4
Net Income
-54.42-43.95-27.8-14.4
Shares Outstanding (Basic)
2317144
Shares Outstanding (Diluted)
2317144
Shares Change
32.51%19.02%278.34%-
EPS (Basic)
-2.39-2.56-1.93-3.78
EPS (Diluted)
-2.39-2.56-1.93-3.78
Free Cash Flow
-50.87-38.06-24.72-3.44
Free Cash Flow Per Share
-2.24-2.22-1.72-0.90
EBITDA
-54.42-43.94-27.8-14.4
Depreciation & Amortization
0.010.0100
EBIT
-54.42-43.95-27.8-14.4
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).